A process for preparing perindopril (III) or a pharmaceutically acceptable salt thereof, which process comprises a substituted benzyl ester of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (I) with N--[(S)-carbethoxybutyl]-(S)-alanine (II) where R represents a halo, C.sub.1-4 alkoxy or nitro substituent.

 
Web www.patentalert.com

< Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

> Green and orange fluorescent labels and their uses

> Selection of patients with increased responsiveness to botulinum toxin

~ 00584